NYSEAM:ASXC - Post by User
Post by
tamarion Jan 13, 2023 11:28am
200 Views
Post# 35221200
Closing in on 10,000+ proecedures.
Closing in on 10,000+ proecedures.
That's critical mass of machine learning and opens up a lot of opportunities. The commercial launch of articulating instruments in Q4 2022 was a long sought after key surgeon preference item. That must be contributing to recent system placements in Germany and Japan. Expect further traction now that we're moving on from Covid.
Today's breakout of the compressed moving averages is very positive. Haven't seen that for 2 years.